- AuthorisedTherapeutic confirmatory (Phase III)
Postoperative recovery with the addition of long-acting NK1- and 5-HT3 receptor antagonists as prophylaxis for post-operative nausea and vomiting. A prospective, double-blind, randomized trial in laparoscopic surgery.
This study is looking at new ways to prevent sickness and vomiting after stomach surgery. It tests different medicines to see which ones help patients recover better and feel less sick after their operation. The goal is to make recovery an easier experience for people.
For: Post-operative nausea and vomiting (PONV)Sweden - AuthorisedTherapeutic exploratory (Phase II)
J2R-MC-YAAD: A Phase 2, Double-blind, Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease
This study is looking into a new medicine called LY3537021 (also known as Lagipra) to help prevent sickness and vomiting caused by chemotherapy. It compares the new medicine to a dummy pill (placebo) and other common anti-sickness treatments in adults having cancer treatment.
For: Drug-Related Side Effects and Adverse Reactions · Nausea · NeoplasmsRomania · Spain · France